For more information contact Leaura Levine, Marketing Associate.
Siemens Healthcare Diagnostics, Inc. Selects Cambridge Discovery Park
October 23, 2008
CAMBRIDGE, MASS – October 23, 2008 - The Bulfinch Companies, Inc., a Needham-based real estate investment and development firm, is pleased to announce that Siemens Healthcare Diagnostics, Inc. has leased the entire sixth floor measuring 22,442 square feet in the Smithsonian Astrophysical Institute Observatory, at Cambridge Discovery Park, Cambridge, MA.
Cambridge Discovery Park is a prominent twenty-seven-acre campus in Cambridge, masterplanned to accommodate an additional 700,000 SF in multiple LEED certified office, laboratory and research and development buildings when fully completed. The park fronts Route 2 and is in close proximity to Route 128, the Alewife MBTA station, Downtown Boston and a host of retail, banking and hotel amenities. The recent completion of the six-story Smithsonian Astrophysical Institute Observatory signaled the first phase of development within the park.
Oncogene Science Biomarker Group, the division of Siemens that will occupy the sixth floor, develops, manufactures, and markets high quality, ready-to-use cancer reagent systems for commercial and clinical research customers worldwide and is a leader in developing new biomarker assays to further advance oncology care. Siemens acquired Oncogene in 1999.
Curtis Cole, Chuck Kavoogian and Adam Brinch of CB Richard Ellis New England represented Siemens and Jon Varholak and Eric Smith of Richards Barry Joyce & Partners represented the Landlord.
According to Michael Wilcox, vice president, director of leasing at Bulfinch, “Cambridge Discovery Park is an ideal setting for a premiere research company such as Siemens. We are pleased that they selected CDP for their office and laboratory operations, where they will join other leading research firms such as FoldRx, the Harvard-Smithsonian Astrophysical Institute and TIAX, LLC. We look forward to accommodating Siemens’ growing needs as the park evolves into future phases of development to its 820,000 square foot build-out.”
Bulfinch is an entrepreneurial, value-added real estate investment firm specializing in the development, acquisition, management, and repositioning of commercial properties in greater Boston. Since its inception in 1936, Bulfinch has developed, acquired and repositioned approximately $1 billion dollars in commercial real estate.
###